Icon

NULIBRY (nda214018)- (EQ 9.5MG BASE/VIAL)

FOSDENOPTERIN HYDROBROMIDE SENTYNL THERAPS INC
EQ 9.5MG BASE/VIAL
No No
2025-Jan-31 2026-Feb-26
None None
None No
NULIBRY is cyclic pyranopterin monophosphate (cPMP) indicated to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 9.5MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.